Rhenman & Partners Asset Management AB
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1599882
Stockholm, V7
Position in ADPT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,993,600
+$168,400 QoQ
Shares Held
720,000
+19.0% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $73,822,363 across 8 Diagnostics & Research names. ADPT ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
41,340 | $20,319,850 | |
| 2 | GH |
Guardant Health, Inc.
|
145,000 | $13,393,650 | |
| 3 | NTRA |
Natera, Inc.
|
51,600 | $10,319,484 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
This page
|
720,000 | $9,993,600 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
53,000 | $9,038,620 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
26,000 | $4,485,000 | |
| 7 | DHR |
Danaher Corp /De/
|
18,052 | $3,422,659 | |
| 8 | A |
Agilent Technologies, Inc.
|
25,000 | $2,849,500 |
All Filings in ADPT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,993,600 | 720,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,825,200 | 605,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,405,200 | 495,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||